These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4448349)

  • 1. [3,4,5-trimethoxylbenzoyl-epsilon-amino.....aminocaproic acid in acute myocardial infarction. (author's transl)].
    Masini V; Floris B; Santini M
    G Ital Cardiol; 1974; 4(6):770-2. PubMed ID: 4448349
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of 3,4,5-trimethoxy-benzoyl- epsilon-aminocaproic acid in the acute phase of myocardial infarct].
    Lombardi M; Del Giallo P; Valiensi M; Gramolini C
    Minerva Med; 1971 Dec; 62(97):4855-63. PubMed ID: 5131193
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sodium 3,4-5-trimethoxy-benzoyl-epsilon-amino-caproate (C-tre) in the treatment of acute myocardial infarct].
    Longhini I; Razzaboni G; Gramolini C; Casoni T; Ferracioli GF
    Minerva Med; 1973 Aug; 64(59):3080-90. PubMed ID: 4742648
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of myocardial infarct with 3,4,5-trimethoxy-benzoyl-amino-caproic acid or C-3. Observations on 60 cases studied in an intensive coronary care unit].
    D'Alonzo D; Svetoni N; Zaccherotti L
    Minerva Cardioangiol; 1973 Apr; 21(4):298-303. PubMed ID: 4710126
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombelastographic evaluation of hemocoagulation in acute myocardial infarct treated with sodium 3,4,5 trimethoxybenzoylaminocaproate].
    Zangara A; Dugoni D; Anselmi L
    Minerva Med; 1973 Mar; 64(16):803-11. PubMed ID: 4704724
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of trimethoxy-benzoyl-aminocaproate sodium (C-3) in the initial phase of myocardial infarct].
    Napolitano D; Improta M; Cuomo A; Bonagura A
    Minerva Med; 1971 Dec; 62(98):4888-905. PubMed ID: 5141916
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of the use of 3-4-5-trimethoxybenzoyl-epsilon-amino-caproic acid (C-3) in acute phase of myocardial infarct].
    De' Thomatis M; Oddone G
    Minerva Med; 1974 Feb; 65(12):650-6. PubMed ID: 4132079
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trial therapy with 3,4,5 trimethoxybenzoyl-epsilon-aminocaproic acid in acute myocardial infarct].
    Selvini A; Belli C; Corallo S; Gramolini C; Ferrari ML
    G Ital Cardiol; 1973 May; 3(5):661-73. PubMed ID: 4589173
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anticomplementary activity of 3,4,5 trimethoxy-benzoyl-epsilon aminocaproic acid as component in the treatment of myocardial infarct].
    Di Perri T; Auteri A
    Boll Soc Ital Cardiol; 1972; 17(12):1218-27. PubMed ID: 4681447
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolic interventions in the treatment of ischemic myocardiopathies].
    Fontanini F; De Giuli S; Mora A; Bossini S; Acquaviva F; Franceschini G
    Minerva Cardioangiol; 1974 Dec; 22(12):827-39. PubMed ID: 4459727
    [No Abstract]   [Full Text] [Related]  

  • 11. [Considerations, premises and promises of new therapeutic prospects in acute myocardial infarct. Preliminary trials of sodium trimethoxy-benzoyl- epsilon-aminocaproate (C3)].
    Fontanini F; Bossini S; Mora A; Greggia A; Razzaboni G; Franceschini G
    Minerva Med; 1969 Dec; 60(97):4857-80. PubMed ID: 5357551
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombelastographic evaluation of blood coagulation in acute myocardial infarct treated with 3,4,5 trimethoxybenzoylaminocaproate sodium].
    Zangara A; Dugoni D; Anselmi L
    Minerva Med; 1973 Mar; 64(16):803-11. PubMed ID: 4723563
    [No Abstract]   [Full Text] [Related]  

  • 13. [Electrocardiographic evolution of cardiac infarct in patients treated with sodium 3,4,5-trimethoxybenzoyl-epsilon-aminocaproate].
    Pittera A; Di Blasi F; Ruvolo F; Midili N; Gramolini C
    Minerva Cardioangiol; 1975 Sep; 23(9):527-60. PubMed ID: 1161165
    [No Abstract]   [Full Text] [Related]  

  • 14. [Protective effect of sodic 3,4,5 trimethoxy-benzoyl-epsilon-amino caproate (C3) in experimental myocardial infarct. 3. Relationship between structure and antipitressin activity in the rat].
    Greggia A; Razzaboni G; Baraldi M; Vergoni W
    Boll Soc Ital Biol Sper; 1969 Nov; 45(22):1449-50. PubMed ID: 5397300
    [No Abstract]   [Full Text] [Related]  

  • 15. [Protective effect of sodic 3,4,5 trimethoxy-benzoyl-epsilon-amino caproate (C3) in experimental myocardial infarct. II. Influence of C3 on arrhythmia induced with pitressin].
    Razzaboni G; Greggia A; Baraldi M; Vergoni W
    Boll Soc Ital Biol Sper; 1969 Nov; 45(22):1448-9. PubMed ID: 5398285
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of 3,4,5-trimethoxy-benzoyl-aminocaproic acid on the cytolytic process in myocardial infarct. Working hypothesis].
    Rosano V; Cangiano G; Lacquaniti B; Miceli F; Vavala V; Leone-Costa M
    Minerva Med; 1975 Dec; 66(83):4496-8. PubMed ID: 1196538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of epsilon-aminocaproic acid in acute pyelonephritis].
    Grabaziuk VS
    Vrach Delo; 1980 Jan; (1):64-6. PubMed ID: 6990619
    [No Abstract]   [Full Text] [Related]  

  • 18. [Protective effect of sodic 3,4,5 trimethoxy-benzoyl-epsilon-amino caproate (C3) in experimental myocardial infarct. I].
    Greggia A; Baraldi M; Razzaboni G; Vergoni W
    Boll Soc Ital Biol Sper; 1969 Nov; 45(22):1447-8. PubMed ID: 5397299
    [No Abstract]   [Full Text] [Related]  

  • 19. [Review of the literature and report of experiments relating to the coronaroactive drug, hexobendine].
    Marmo E; Caputi AP; Cataldi S
    Minerva Cardioangiol; 1972 Oct; 20(10):571-81. PubMed ID: 4562623
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of epsilon-aminocaproic acid in the treatment of acute pancreatits].
    Karavanov AG; Osingolts SL
    Klin Med (Mosk); 1966 May; 44(5):13-5. PubMed ID: 4865586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.